Thin-EBUS in Ex-vivo Human Lungs
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03349307|
Recruitment Status : Completed
First Posted : November 21, 2017
Last Update Posted : May 14, 2018
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer||Device: Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Feasibility of the Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS) System for Lymph Node Staging|
|Actual Study Start Date :||July 12, 2017|
|Actual Primary Completion Date :||May 1, 2018|
|Actual Study Completion Date :||May 1, 2018|
|Experimental: No Intervention||
Device: Thin Convex Probe Endobronchial Ultrasound (TCP-EBUS)
Patients scheduled for a lobectomy will be recruited to this study and approached for informed consent. At the time of surgery, once the lobe has been removed, the TCP-EBUS will be inserted through a bronchial stamp for brief operability evaluations and image acquisition. Once this data has been captured standard of care will continue.
- To clarify the feasibility of using the thin convex probe EBUS scope to visualize lung tumors from an intra bronchial view. [ Time Frame: Within an hour of resection. ]The TCP-EBUS bronchoscope will be inserted through the endotracheal tube for visualization of lobar, segmental and sub segmental bronchi.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03349307
|Toronto General Hospital|
|Toronto, Ontario, Canada, M5G 2C4|